Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nektarios Oraiopoulos

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advances in Therapy|June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug DevelopmentNektarios Oraiopoulos, William C N Dunlop
Frontiers in Pharmacology|June 20, 2017
Lemons, or Squeezed for Resources? Information Symmetry and Asymmetric Resources in BiotechnologyArthur Neuberger, Nektarios Oraiopoulos, Donald L Drakeman
Journal of Market Access & Health Policy|May 27, 2026
Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and CanadaBarry Crean, David Parry, Alison Horsfield, et al.
Therapeutic Innovation & Regulatory Science|June 30, 2023
Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and DeploymentLidia Betcheva, Jennifer Y Kim, Feryal Erhun, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advances in Therapy|June 19, 2017
When Science is Not Enough: A Framework Towards More Customer-Focused Drug DevelopmentNektarios Oraiopoulos, William C N Dunlop
Frontiers in Pharmacology|June 20, 2017
Lemons, or Squeezed for Resources? Information Symmetry and Asymmetric Resources in BiotechnologyArthur Neuberger, Nektarios Oraiopoulos, Donald L Drakeman
Journal of Market Access & Health Policy|May 27, 2026
Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and CanadaBarry Crean, David Parry, Alison Horsfield, et al.
Therapeutic Innovation & Regulatory Science|June 30, 2023
Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and DeploymentLidia Betcheva, Jennifer Y Kim, Feryal Erhun, et al.
Pageof 1